Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

HHS halts work at high-risk infectious disease lab following repeated safety violations

by admin May 2, 2025
May 2, 2025
HHS halts work at high-risk infectious disease lab following repeated safety violations

The Department of Health and Human Services (HHS) implemented a pause on research at one of the nation’s most highly secure research labs, following repeated safety incidents that a source familiar told Fox News Digital have been occurring since the Biden administration.

An HHS official confirmed the pause at Fort Detrick’s Integrated Research Facility, which conducts risky research on deadly infectious diseases like SARS-COV-2 and the Ebola virus, began Tuesday at 5 p.m. 

The facility, which is one of only a handful across North America, is part of the National Institute of Allergy and Infectious Diseases (NIAID) and is located at the U.S. Army base Fort Detrick, outside Washington, D.C. The research there studies treatment and prevention of deadly, ‘high-consequence’ diseases such as Lassa Fever and Eastern equine encephalitis.

According to the HHS official who was willing to speak on the matter under the condition of anonymity, the pause stemmed from a lover’s spat between researchers at the facility, which resulted in one of the individuals poking holes in the other’s personal protective equipment (PPE). That individual has since been fired, the official indicated. 

The HHS official added that the incident is just the latest example of safety incidents at the high-risk laboratory, which they blamed on a poor safety culture at the lab enabled by the previous Biden administration.

‘NIH and HHS take the safety of our facilities and research very seriously,’ HHS spokesperson Andrew Nixon said. ‘As soon as we found out about this incident, we took immediate action to issue the safety pause until we can correct the safety culture at this facility.’

The latest incident, according to HHS, was preceded by a separate incident that occurred as recently as November.

The facility’s director, Connie Schmaljohn, was placed on administrative leave following the incident. The HHS official familiar with the matter indicated Schmaljohn did not report the incident up the chain of command immediately, causing a delay in remedying the matter.

During this temporary pause, all research at the facility will come to a halt and access will be limited to essential personnel. 

It is unclear how long the pause will remain in effect.   

This post appeared first on FOX NEWS

previous post
Iran talks in Rome not happening this weekend and were never confirmed, State Department says
next post
Trump executive order stands up presidential religious liberty commission

related articles

Enemy within: Counterterrorism experts fear sleeper cells could...

March 2, 2026

House conservatives skeptical as Senate deal sacrificing DHS...

January 30, 2026

Oct 7 anniversary: Netanyahu finds unlikely ally amid...

October 7, 2025

Donald Trump Jr takes personal trip to Greenland...

January 7, 2025

GOP outperformed Dems on voter registration in key...

May 22, 2025

Trump, Zelenskyy to meet for key deal as...

February 28, 2025

Leaked documents expose Khamenei’s secret deadly blueprint for...

February 4, 2026

Vance says Trump admin has ‘great’ healthcare plan...

November 21, 2025

EPA scraps Biden coal restrictions, and advocates say...

February 21, 2026

Supreme Court hears pivotal Louisiana election map case...

March 25, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 2

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 3

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 4

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (3,716)
    • Latest News (2,300)
    • Politics (4,600)
    • Stocks (1,442)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved